McKesson
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade McKesson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MCK
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S.
CEOBrian Scott Tyler
CEOBrian Scott Tyler
Employees45,000
Employees45,000
HeadquartersIrving, Texas
HeadquartersIrving, Texas
Founded1833
Founded1833
Employees45,000
Employees45,000
MCK Key Statistics
Market cap98.76B
Market cap98.76B
Price-Earnings ratio31.41
Price-Earnings ratio31.41
Dividend yield0.37%
Dividend yield0.37%
Average volume554.93K
Average volume554.93K
High today$794.52
High today$794.52
Low today$782.52
Low today$782.52
Open price$792.64
Open price$792.64
Volume97.69K
Volume97.69K
52 Week high$794.52
52 Week high$794.52
52 Week low$492.39
52 Week low$492.39
MCK News
Nasdaq 2d
Citius Oncology Inks Distribution Services Agreement With McKesson For LYMPHIR(RTTNews) - Citius Oncology, Inc. (CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (CTXR), announced Monday it has entered into a distrib...
TipRanks 2d
Citius Oncology announces distribution agreement with McKessonCitius Oncology (CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (CTXR), announced it has entered into a distribution services agreement with M...
Simply Wall St 3d
Is McKesson's Role in PHYRAGO's Launch Revealing Its Specialty Pharma Ambitions?Earlier this month, Cycle Pharmaceuticals announced the US launch of PHYRAGO, its first oncology product, in partnership with Handa Therapeutics, with exclusive...
Analyst ratings
79%
of 19 ratingsBuy
78.9%
Hold
15.8%
Sell
5.3%
People also own
Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.